Blood thinner trombix under Real-World review for heart rhythm disorder

NCT ID NCT06184204

Completed Disease control Sponsor: Beker Laboratories Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study in Algeria followed 398 adults with atrial fibrillation who were taking the blood thinner Trombix (Rivaroxaban). The goal was to see how safe and effective the drug is in everyday medical practice, and how it affects quality of life. Researchers tracked serious bleeding events and other side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Rivaroxaban (brand name Trombix), a blood thinner
What this could lead to: If results are positive, this could confirm that Trombix is a safe and effective option for managing atrial fibrillation in real-world settings in Algeria.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

AOUICHE private healthcare

Constantine, Algeria
Ali Lahmar private healthcare

Oran, Algeria
BEDAI private healthcare

Annaba, Algeria
Berboucha

Annaba, Algeria
Boudjelal private healthcare

Batna City, Algeria
Boumaaza Private healthcare

Algiers, Algeria
CHU Mustapha

Algiers, Algeria
CHU Oran

Oran, Algeria
EID private healthcare

Oran, Algeria
EPH Tipaza

Tipasa, Algeria
Fernane private healthcare

Tizi Ouzou, Algeria
HAMDI private healthcare

Constantine, Algeria
KHAITER Private healthcare

Blida, Algeria
Mouffok private healthcare

M'Sila, Algeria
NASSOUR private healthcare

Tlemcen, Algeria
OKBI Private healthcare

Biskra, Algeria
Sebbagh Private Healthcare

Sidi Bel Abbes, Algeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.